Other
Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, after Year One Through Five
Medtronic Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, after Year One Through Five increased by 7.0% to $3.13B in Q4 2025 compared to the prior quarter. Year-over-year, this metric declined by 1.9%, from $3.19B to $3.13B.
Analysis
StatementBalance Sheet Statement
SectionOther
CategoryLiquidity
SignalContext dependent
VolatilityStable
First reportedQ3 2016
Last reportedQ3 2026Feb 24, 2026
How to read this metric
An increase indicates a shift toward longer-duration assets, potentially to capture higher yields in a stable interest rate environment.
Detailed definition
This represents the fair value of available-for-sale debt securities that have maturity dates falling between one and fi...
Peer comparison
Commonly disclosed in the notes to financial statements for companies with substantial investment portfolios.
Metric ID:
other_available_for_sale_securities_debt_maturities_afte_540252Historical Data
15 periods
| Q1 '22 | Q2 '22 | Q3 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q1 '26 | Q2 '26 | Q3 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $2.98B | $3.20B | $3.34B | $3.60B | $3.65B | $3.71B | $3.80B | $3.74B | $3.71B | $3.33B | $3.25B | $3.19B | $3.02B | $2.92B | $3.13B |
| QoQ Change | — | +7.4% | +4.3% | +7.8% | +1.4% | +1.6% | +2.5% | -1.6% | -0.8% | -10.3% | -2.3% | -1.9% | -5.3% | -3.1% | +7.0% |
| YoY Change | — | — | — | +20.8% | +14.1% | +11.1% | +5.6% | +2.4% | +0.0% | -12.5% | -13.1% | -14.1% | -9.3% | -10.1% | -1.9% |
Range$2.92B – $3.80B
CAGR+1.4%
Avg YoY Growth-0.6%
Median YoY Growth-0.9%
Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, after Year One Through Five at Other Companies
Frequently Asked Questions
- What is Medtronic's debt securities, available-for-sale, fair value, maturity, allocated and single maturity date, after year one through five?
- Medtronic (MDT) reported debt securities, available-for-sale, fair value, maturity, allocated and single maturity date, after year one through five of $3.13B in Q4 2025.
- How has Medtronic's debt securities, available-for-sale, fair value, maturity, allocated and single maturity date, after year one through five changed year-over-year?
- Medtronic's debt securities, available-for-sale, fair value, maturity, allocated and single maturity date, after year one through five decreased by 1.9% year-over-year, from $3.19B to $3.13B.
- What does debt securities, available-for-sale, fair value, maturity, allocated and single maturity date, after year one through five mean?
- The value of debt investments maturing between one and five years from now.